Danco Labs seeks Supreme Court block of limits on mail‑order mifepristone
Fast facts
- Category: United States
- Language: EN
- Published: 2026-05-02 13:41 UTC
- Sources: The Hill
Danco Laboratories, maker of the abortion pill mifepristone, filed an emergency petition with the Supreme Court asking it to halt a federal appeals court order that restricts telehealth prescribing and mail‑order dispensing of the medication. The company argues the ruling impedes reproductive‑health access.
Why it matters
- This update can influence the United States agenda over the next 24-48 hours.
- It is based on 1 source, which helps cross-check key claims quickly.
- Watch follow-up statements and market/public response to assess real impact.